8-K: Glucotrack Amends Financing Agreement

Glucotrack, Inc. has amended its Common Stock Purchase Agreement with White Lion Capital, LLC, adjusting terms related to commitment shares and potential future payments.

Summary

• Glucotrack, Inc. entered into Amendment No. 1 to its Common Stock Purchase Agreement with White Lion Capital, LLC on August 7, 2026.
• The amendment modifies the issuance of Commitment Shares, which will be 2,505,513 shares of Common Stock.
• These shares will be issued within one business day after the resale registration statement becomes effective.
• A new provision addresses a potential 'True-Up Amount' if the Commitment Fee Price is less than the Minimum Price, requiring Glucotrack to pay the difference between $1,000,000 and the product of 2,505,513 shares multiplied by the Commitment Fee Price.
• This True-Up Amount, if owed, must be paid within 120 days following the Measurement Date.
• No True-Up Amount is owed if the Commitment Fee Price meets or exceeds the Minimum Price.
• The issuance of Commitment Shares is exempt from registration under the Securities Act of 1933, pursuant to Section 4(a)(2) and Rule 506(b).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative development, primarily due to the modification of an existing financing agreement that introduces potential future financial obligations and dilutive share issuances.

Positives

• The amendment clarifies the terms for issuing Commitment Shares, providing a defined number of 2,505,513 shares.
• The agreement provides a mechanism for potential future financing, with the issuance of shares tied to the effectiveness of a resale registration statement.

Negatives

• The amendment introduces a potential 'True-Up Amount' that could result in a future financial obligation for the Company if the Commitment Fee Price is below the Minimum Price.
• The issuance of 2,505,513 Commitment Shares represents potential dilution to existing shareholders.
• The True-Up Amount, if triggered, must be paid within 120 days following the Measurement Date, creating a near-term financial commitment.

Risks

• The primary risk is the potential obligation to pay a 'True-Up Amount' if the Commitment Fee Price falls below the Minimum Price, which could impact the Company's cash flow.
• Further dilution of common stock may occur upon the issuance of Commitment Shares.
• The effectiveness of the resale registration statement is a condition for the issuance of Commitment Shares, introducing a dependency on regulatory processes.

Future Outlook

The future outlook is contingent on the effectiveness of the resale registration statement and the market price of the Company's common stock relative to the Minimum Price. If the Commitment Fee Price is less than the Minimum Price, the Company may have a financial obligation to pay a True-Up Amount within 120 days of the Measurement Date.

Management Comments

• The Company entered into Amendment No. 1 to the Common Stock Purchase Agreement with White Lion Capital, LLC.
• The Amendment modifies Section 6.4(a) and adds Section 6.4(b) to the ELOC Purchase Agreement.

Industry Context

StockSavvy.ai notes that amendments to equity financing agreements are common for companies seeking capital, especially those in growth phases or with fluctuating stock prices. The inclusion of a 'True-Up Amount' suggests a mechanism to protect the investor's commitment value in a volatile market, which is a strategy seen in various venture debt and equity financing structures.

Related Party Transactions

• The filing details an amendment to a Common Stock Purchase Agreement between Glucotrack, Inc. and White Lion Capital, LLC. White Lion Capital, LLC is identified as the Investor.

Stakeholder Impact

• Shareholders may experience dilution due to the issuance of 2,505,513 Commitment Shares.
• Creditors and other stakeholders may be impacted by the potential future financial obligation related to the True-Up Amount, affecting the Company's liquidity.

Next Steps

• The Company will issue 2,505,513 Commitment Shares to the Investor within one business day following the effectiveness of the resale registration statement.
• If the Commitment Fee Price is less than the Minimum Price, the Company may be required to pay the True-Up Amount to the Investor within 120 days following the Measurement Date.
• The Company must ensure the resale registration statement becomes effective.

Key Dates

Recommendation

The amendment to the financing agreement introduces potential dilution and a contingent financial obligation, creating uncertainty. While it clarifies a financing path, the potential for a true-up payment and the dependence on registration statement effectiveness warrant a cautious 'hold' stance until further clarity on the company's financial performance and market conditions emerges.

Keywords

Common Stock Purchase Agreement, Financing Amendment, Commitment Shares, White Lion Capital, Resale Registration Statement, Dilution, Capital Raise